Mercy BioAnalytics
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.
$59M Series B+ ·
Led by Novalis LifeSciences · Source: fundraisingfox.com
Total raised: $100M across 2 sourced rounds
All 2 rounds ↓Signals
Website registeredMar 11, 2018 (8 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $59M | fundraisingfox.com | ||
| Series A | $41M | fundraisingfox.com |
Timeline
- Website created
Founders and team
DM
Dawn Mattoon FounderJS
Joseph Sedlak FounderPB
Paul Blavin FounderDC
Darrin Crisitello Chief Commercial OfficerES
Ellen Snow Chief Financial OfficerPR
Prasanth Reddy Chief Medical Officer
Investors
AAvestria Ventures
BBrightEdge - American Cancer Society
BBroadway Angels
BBruker
HHatteras Venture Partners
HHologic
IiSelect Fund
LLabCorp
MMindshift Capital
NNovalis LifeScienceslead investor
- PPerceptive Xontogeny Venture Fund
PPortfolia
SSozo Ventureslead investor
Companies like Mercy BioAnalytics
PPrima MenteSeed · Apr 2026
SSyantra$3.6M Series A · Sep 2024
CCellCentric$220M Series B+ · May 2026
CCraif$33M Series B+ · Aug 2026
CCity TherapeuticsSeries B+ · Aug 2026
SSaku BiosciencesSeed · May 2026
Other companies backed by Novalis LifeSciences
EeTheRNA Immunotherapies$39M Series B+ · Aug 2022
OOri Biotech$100M Series B+ · Jan 2022
Novalis LifeSciences portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mercy-bioanalytics (get a free API key).